S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration
Clinical trial NCT04071457 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04071457
- Sponsor
- SWOG Cancer Research Network
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-13
- Primary completion
- 2029-07-01
- Enrollment
- 1100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.